Inhibition of STAT3 Reverses the Resistance to Histone Deacetylase Inhibitors Induced By Interleukin-6 in Chronic Lymphocytic Leukemia Cells

被引:0
|
作者
Lu, Kang [1 ]
Wang, Xin [1 ,2 ]
Fang, Xiaosheng [1 ]
Feng, Lili [1 ]
Chen, Na [1 ]
Li, Peipei [1 ]
Li, Xinyu [1 ]
Geng, Lingyun [1 ]
机构
[1] Shandong Univ, Prov Hosp, Jinan 250100, Peoples R China
[2] Shandong Univ, Jinan 250100, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia
    Lai, R
    O'Brien, S
    Maushouri, T
    Rogers, A
    Kantarjian, H
    Keating, M
    Albitar, M
    CANCER, 2002, 95 (05) : 1071 - 1075
  • [42] INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 REVERSES ENZALUTAMIDE RESISTANCE IN LNCAP DERIVATIVE PROSTATE CANCER CELLS
    Liu, Chengfei
    Zhu, Yezi
    Lou, Wei
    Cui, Yuanyuan
    Evans, Christopher P.
    Gao, Allen C.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E262 - E262
  • [43] Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cells
    Lee, Eun-Sang
    Ko, Kyung-Kon
    Joe, Young Ae
    Kang, Seok-Gu
    Hong, Yong-Kil
    ONCOLOGY LETTERS, 2011, 2 (01) : 115 - 121
  • [44] Inhibition of Constitutively Active Stat3 Reverses Enzalutamide Resistance in LNCaP Derivative Prostate Cancer Cells
    Liu, Chengfei
    Zhu, Yezi
    Lou, Wei
    Cui, Yuanyuan
    Evans, Christopher P.
    Gao, Allen C.
    PROSTATE, 2014, 74 (02): : 201 - 209
  • [45] Chronic CNS expression of interleukin-6 produces changes in expression of STAT3 in transgenic mice.
    Kishikawa, H
    Castro, C
    Ling, C
    Potvin, D
    Lawrence, DA
    Turner, JN
    Campbell, IL
    Shain, W
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S73 - S73
  • [46] Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway
    X. Li
    H. Miao
    Y. Zhang
    W. Li
    Z. Li
    Y. Zhou
    L. Zhao
    Q. Guo
    Archives of Toxicology, 2015, 89 : 121 - 136
  • [47] Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway
    Li, X.
    Miao, H.
    Zhang, Y.
    Li, W.
    Li, Z.
    Zhou, Y.
    Zhao, L.
    Guo, Q.
    ARCHIVES OF TOXICOLOGY, 2015, 89 (01) : 121 - 136
  • [48] Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells
    Shi, Yingfeng
    Tao, Min
    Ni, Jun
    Tang, Lunxian
    Liu, Feng
    Chen, Hui
    Ma, Xiaoyan
    Hu, Yan
    Zhou, Xun
    Qiu, Andong
    Zhuang, Shougang
    Liu, Na
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] Constitutively Activated STAT3 Induces the Expression of Gli1 in Chronic Lymphocytic Leukemia Cells
    Rozovski, Uri
    Harris, David M.
    Li, Ping
    Liu, Zhiming
    Manshouri, Taghi
    Veletic, Ivo
    Jain, Preetesh
    Ferrajoli, Alessandra
    Burger, Jan A.
    Bose, Prithviraj
    Thompson, Philip A.
    Jain, Nitin
    Verstovsek, Srdan
    Wierda, William G.
    Keating, Michael J.
    Estrov, Zeev E.
    BLOOD, 2019, 134
  • [50] Microenvironmental Interleukin-6 induced activation of STAT3 signaling in medulloblastoma: Implications for molecular pathology and therapy
    Yan, Shuang
    Chatterjee, Sampurna
    Vardam, Trupti
    Kitahara, Shuji
    Hato, Tai
    Roberge, Sylvie
    Askoxylakis, Vasileios
    Duquette, Mark
    Fukumura, Dai
    Xu, Lei
    Jain, Rakesh
    CANCER RESEARCH, 2016, 76